Add Company
Join Now

Cascadian Therapeutics Revenue and Competitors

License our Company Data API

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cascadian Therapeutics's estimated annual revenue is currently $2.5M per year.(i)
  • Cascadian Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Cascadian Therapeutics has 16 Employees.(i)
  • Cascadian Therapeutics grew their employee count by -11% last year.

Cascadian Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$5.1M336%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M48-21%$16MN/A
#7
$1.1M70%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M5-17%N/AN/A
Add Company

What Is Cascadian Therapeutics?

Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. Our goal is to discover, develop and commercialize novel compounds that have the potential to improve the lives and outcomes of cancer patients. Our most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor. We are headquartered in Seattle, Washington. For more information, visit www.cascadianrx.com.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cascadian Therapeutics News

2022-04-20 - Serine/Threonine Protein Kinase Chk1 Competitive Market ...

... 2022 Segments, Competitors Strategy, Regional Analysis, Key Players |CanBas Co Ltd, Cascadian Therapeutics Inc, Eli Lilly and Company, Genentech Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M16N/AN/A
#2
$1.3M16N/AN/A
#3
$2.5M16-24%N/A
#4
$2.5M167%N/A
#5
$1.4M167%N/A